Search Results for keywords:"cancer research"

The National Cancer Institute has announced a change to the schedule of the Special Emphasis Panel meeting on clinical and translational cancer research. Originally scheduled to end at 7 p.m. on February 5, 2025, the meeting will now conclude earlier, at 2 p.m. The meeting, held from February 4-5, 2025, will take place at the National Cancer Institute in Rockville, Maryland, and will remain closed to the public.

The National Cancer Institute announced that it will hold two closed meetings in March 2025 to discuss and evaluate grant applications. The meetings will not be open to the public because they might involve discussing confidential information like trade secrets and personal data. Both meetings will be held virtually from the National Cancer Institute in Rockville, Maryland. The meetings aim to focus on different aspects of cancer research, including clinical and translational research, and biospecimen science approaches.

The National Cancer Institute announced closed meetings for a committee focusing on diet, lipid metabolism, and cancer. These meetings will be held on April 8, 2025, from 9:30 a.m. to 3:00 p.m. The meetings are virtual and not open to the public to protect confidential information and personal privacy. The meeting will review and evaluate grant applications related to cancer research, and the contact person is Dr. Shree Ram Singh.

The National Cancer Institute, part of the National Institutes of Health, has announced several upcoming meetings. These meetings, scheduled between January and March 2025, are intended to evaluate grant applications and contract proposals related to cancer research. The meetings will be closed to the public to protect confidential information and personal privacy. Each meeting will take place virtually, and further details, including contact information for scientific review officers, are provided for each session.

The National Cancer Institute has announced several closed meetings in accordance with the Federal Advisory Committee Act. These meetings will not be open to the public to protect sensitive information like trade secrets and personal details of individuals involved in grant applications and contract proposals. Notable meetings include sessions to evaluate contract proposals and grant applications relating to cancer research, occurring throughout March 2021. For more information, individuals can contact the Scientific Review Officers listed in the notice.

During Cancer Control Month in April 2025, a proclamation underscores the importance of supporting cancer patients and celebrating survivors. President Donald J. Trump highlights efforts to advance medical research and technology to combat cancer, noting the establishment of the Make America Healthy Again Commission. The proclamation encourages Americans to maintain healthy lifestyles and utilize early screenings to help prevent and detect cancer. It also recognizes declining cancer death rates and urges continued innovation and dedication to finding a cure.

The National Cancer Institute has announced a series of upcoming meetings that will be closed to the public as per the Federal Advisory Committee Act. These meetings, taking place between February and April 2021, will focus on reviewing and evaluating grant applications related to cancer research. The discussions might reveal confidential information such as trade secrets or personal details, justifying their privacy. Interested parties can learn more by contacting the respective Scientific Review Officers listed for each session.

The Center for Scientific Review is holding a series of closed meetings to evaluate grant applications, as per the Federal Advisory Committee Act. These meetings, scheduled for early March 2021, will discuss sensitive information, such as trade secrets and personal data, which warrant privacy. Meetings will take place virtually at the National Institutes of Health in Bethesda, MD, and cover diverse topics including fellowships in genetics, drug discovery, and cancer research. Contact details for various Scientific Review Officers involved are provided for those needing more information.

The National Cancer Institute has announced upcoming closed meetings to review grant applications and contract proposals. These meetings will be held virtually and will be closed to the public due to the sensitive nature of the information, which may include confidential trade secrets or personal information. Various meetings are scheduled from February 12 to March 20, 2025, focusing on different research topics such as cancer stigma, clinical and translational cancer research, and small business innovation research. Contact details for each meeting's scientific review officer are provided for further inquiries.

The National Cancer Institute announced several upcoming closed meetings to review grant applications and contract proposals. These meetings will not be open to the public to protect confidential information and personal privacy. Each meeting is led by a Scientific Review Officer, and the topics include reviews for SBIR contracts, clinical and translational research, and various other cancer research initiatives. The meetings will take place via telephone conference calls from late February through early April 2021.